Okedi European Union - English - EMA (European Medicines Agency)

okedi

laboratorios farmacéuticos rovi, s.a. - risperidone - schizophrenia - psycholeptics - treatment of schizophrenia in adults for whom tolerability and effectiveness has been established with oral risperidone.

CRUSIA 2000 IU (20 mg)0.2 ml Solution for Injection in Pre-filled Syringe Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

crusia 2000 iu (20 mg)0.2 ml solution for injection in pre-filled syringe

unimed sdn bhd - enoxaparin sodium -

CRUSIA 4000 IU (40 mg)0.4 ml Solution for Injection in Pre-filled Syringe Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

crusia 4000 iu (40 mg)0.4 ml solution for injection in pre-filled syringe

unimed sdn bhd - enoxaparin sodium -

CRUSIA 6000 IU (60 mg)0.6 ml Solution for Injection in Pre-filled Syringe Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

crusia 6000 iu (60 mg)0.6 ml solution for injection in pre-filled syringe

unimed sdn bhd - enoxaparin sodium -

CRUSIA 8000 IU (80 mg)0.8 ml Solution for Injection in Pre-filled Syringe Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

crusia 8000 iu (80 mg)0.8 ml solution for injection in pre-filled syringe

unimed sdn bhd - enoxaparin sodium -

Eravac European Union - English - EMA (European Medicines Agency)

eravac

laboratorios hipra, s.a. - inactivated rabbit haemorrhagic disease type 2 virus (rhdv2), strainv-1037 - inactivated viral vaccines - rabbits - for active immunisation of rabbits from the age of 30 days to reduce mortality caused by the rabbit haemorrhagic disease type 2 virus (rhdv2)

Eryseng European Union - English - EMA (European Medicines Agency)

eryseng

laboratorios hipra, s.a. - erysipelothrix rhusiopathiae, strain r32e11 (inactivated) - immunologicals for suidae, inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) escherichia + clostridium - pigs - for the active immunisation of male and female pigs to reduce clinical signs (skin lesions and fever) of swine erysipelas caused by erysipelothrix rhusiopathiae, serotype 1 and serotype 2.

Eryseng Parvo European Union - English - EMA (European Medicines Agency)

eryseng parvo

laboratorios hipra, s.a. - porcine parvovirus, strain nadl-2 and erysipelothrix rhusiopathiae, strain r32e11 (inactivated) - immunologicals for suidae, inactivated viral and inactivated bacterial vaccines - pigs - for the active immunisation of female pigs for the protection of progeny against transplacental infection caused by porcine parvovirus.for the active immunisation of male and female pigs to reduce clinical signs (skin lesions and fever) of swine erysipelas caused by erysipelothrix rhusiopathiae, serotype 1 and serotype 2.

Evalon European Union - English - EMA (European Medicines Agency)

evalon

laboratorios hipra, s.a. - vaccine against coccidiosis in chickens - live parasitic vaccines, immunologicals for aves - chicken - for active immunisation of chicks from 1 day of age to reduce clinical signs (diarrhoea), intestinal lesions and oocysts output associated with coccidiosis caused by eimeria acervulina, eimeria brunetti, eimeria maxima, eimeria necatrix and eimeria tenella.,

Hiprabovis IBR Marker Live European Union - English - EMA (European Medicines Agency)

hiprabovis ibr marker live

laboratorios hipra s.a - live ge- tk- double-gene-deleted bovine herpes virus type 1, strain ceddel: 106.3–107.3 ccid50 - immunologicals - cattle - for the active immunisation of cattle from three months of age against bovine herpes virus type 1 (bohv-1) to reduce the clinical signs of infectious bovine rhinotracheitis (ibr) and field virus excretion.onset of immunity: 21 days after completion of the basic vaccination scheme.duration of immunity: 6 months after completion of the basic vaccination scheme